Recro Pharma (REPH:NASDAQ) Investor Relations Material

Overview

Recro Pharma is a specialty pharmaceutical company that generates revenue by selling products to hospitals and ambulatory care settings. The company is primarily focused on developing non-opioid products for treating acute pain. Recro Pharma is a fast-growing biotechnology company and aims to offer alternative treatments for people suffering from pain other than opioid medication. The company is focused on building a strong pipeline of products to cater to the needs of healthcare providers and patients. Recro Pharma is a promising pharmaceutical company with a mission to transform the pain management sector.

Frequently Asked Questions

What is Recro Pharma's ticker?

Recro Pharma's ticker is REPH

What exchange is Recro Pharma traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Recro Pharma's headquarters?

They are based in Malvern, Pennsylvania

How many employees does Recro Pharma have?

There are 201-500 employees working at Recro Pharma

What is Recro Pharma's website?

It is http://www.recropharma.com/

What type of sector is Recro Pharma?

Recro Pharma is in the Healthcare sector

What type of industry is Recro Pharma?

Recro Pharma is in the Biotechnology industry

Who are Recro Pharma's peers and competitors?

The following five companies are Recro Pharma's industry peers:

- Silence Therapeutics plc

- Immunic

- Eton Pharmaceuticals

- Marker Therapeutics, Inc.

- MorphoSys